Belrapzo
Term · Oncology and biomedicine · MLC-T-ONC-000977
A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Belrapzo damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called bendamustine hydrochloride, Bendeka, and Treanda.
| Identifier | MLC-T-ONC-000977 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bendamustine hydrochloride; Bendeka; Treanda |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000977",
"term": "Belrapzo",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Belrapzo damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called bendamustine hydrochloride, Bendeka, and Treanda.",
"synonyms": [
"bendamustine hydrochloride",
"Bendeka",
"Treanda"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/belrapzo/"
}
Record 3,408 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.